Combined flu and COVID-19 vaccine for adults 65 and older
Part of Infections, Lungs & breathing clinical trials.
This trial tests a single combined vaccine that protects against both influenza (flu) and COVID-19. It aims to see how well it works in adults aged 65 and older, potentially offering simpler protection with one shot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years of age or older
- You can understand spoken and written English or Danish (if you are in Denmark) or Spanish or Galician (if you are in Spain)
- You are willing to sign a consent form
- There are no other specific restrictions to join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a flu vaccine (split virus type) for adults aged 60+ to see how well it works and how safe it is. It might help protect older adults from the flu.
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
This trial tests an experimental mRNA flu vaccine in healthy adults ages 18 to 59. Researchers want to see if it is safe and helps the body build protection against the flu.
This study looks at getting an influenza (flu) vaccine in adults age 75 and older. It may help doctors understand how to safely give flu shots to older adults.
This trial tests a new flu vaccine with an ingredient to boost your immune response. It's for adults who haven't had the flu or a flu shot in the past 6 months and are generally healthy.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.